ACE BIOSCIENCES ApS

Dissolved after merger, 11 Sep 2019

CVR 25616715Private limited company (ApS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)København ØFounded 15 Sep 2000

Ownership

People

Network

Financials

Changes

Dandex has recorded no changes to this company since it began following the register.

Registry Facts

Registrations (Registreringer)

Registration

Address: Langelinie Allé 35
2100 København Ø
København Municipality
CVR record last changed: 14 Aug 2026
Data read: 8 Nov 2026

Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Dandex in Your Own Tools

Dandex is Danish company data. Connect it once and ask about ACE BIOSCIENCES ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.

Set Up Dandex

Period	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	Q1 2010	Q2 2010
Employees	0	26	36	34	20	20	18	19	21	3	No count	No count
FTE	1	16	32	32	26	18	16	16	17	13	1	1
Series	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Quarterly	Quarterly

Metric	2014	2015	2016	2017	2018
Revenue	Not reported	Not reported	21,006	17,972	14,243
Operating profit	Not reported	Not reported	+1,191	+1,250	+1,832
Result for the year	+28,476	+414	+8,375	+545	+658
Equity	3,416	3,830	12,205	13,160	15,179
Total assets	41,558	5,959	15,664	16,054	18,284
Credit metrics (Dandex calculations)
Revenue growth (omsætningsvækst)	Not reported	Not reported	62.5%	-14.4%	-20.8%
EBIT margin (overskudsgrad)	Not reported	Not reported	5.7%	7%	12.9%
EBITDA	32,608^{note 1}	745^{note 1}	1,426^{note 2}	1,720^{note 2}	2,007^{note 2}
EBITDA margin	Not reported	Not reported	6.8%^{note 2}	9.6%^{note 2}	14.1%^{note 2}
Net interest-bearing debt (NIBD, nettorentebærende gæld)	-1,135^{note 3}	-1,881^{note 3}	Not reported^{note 4}	-1,697^{note 3}	-9,231^{note 3}
Gearing, NIBD / EBITDA	Net cash^{note 5}	Net cash^{note 5}	Not reported^{note 4}	Net cash^{note 6}	Net cash^{note 6}
ROIC (afkast af investeret kapital)	n.m.^{note 7}	27%^{note 8}	Not reported^{note 4}	6.9%^{note 3}	18.1%^{note 3}
Capex (investeringer i anlægsaktiver)	Not reported^{note 9}	840^{note 10}	892^{note 10}	367^{note 10}	Not reported^{note 11}
Capex % of sales (investeringer i procent af omsætningen)	Not reported	Not reported	4.3%^{note 10}	2%^{note 10}	Not reported^{note 11}
NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender)	-5,633^{note 3}	-2,136^{note 3}	Not reported^{note 4}	-5,021^{note 3}	-7,081^{note 3}

Period	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	Q1 2010	Q2 2010
Employees	0	26	36	34	20	20	18	19	21	3	No count	No count
FTE	1	16	32	32	26	18	16	16	17	13	1	1
Series	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Quarterly	Quarterly

Metric	2014	2015	2016	2017	2018
Revenue	Not reported	Not reported	21,006	17,972	14,243
Operating profit	Not reported	Not reported	+1,191	+1,250	+1,832
Result for the year	+28,476	+414	+8,375	+545	+658
Equity	3,416	3,830	12,205	13,160	15,179
Total assets	41,558	5,959	15,664	16,054	18,284
Credit metrics (Dandex calculations)
Revenue growth (omsætningsvækst)	Not reported	Not reported	62.5%	-14.4%	-20.8%
EBIT margin (overskudsgrad)	Not reported	Not reported	5.7%	7%	12.9%
EBITDA	32,608^{note 1}	745^{note 1}	1,426^{note 2}	1,720^{note 2}	2,007^{note 2}
EBITDA margin	Not reported	Not reported	6.8%^{note 2}	9.6%^{note 2}	14.1%^{note 2}
Net interest-bearing debt (NIBD, nettorentebærende gæld)	-1,135^{note 3}	-1,881^{note 3}	Not reported^{note 4}	-1,697^{note 3}	-9,231^{note 3}
Gearing, NIBD / EBITDA	Net cash^{note 5}	Net cash^{note 5}	Not reported^{note 4}	Net cash^{note 6}	Net cash^{note 6}
ROIC (afkast af investeret kapital)	n.m.^{note 7}	27%^{note 8}	Not reported^{note 4}	6.9%^{note 3}	18.1%^{note 3}
Capex (investeringer i anlægsaktiver)	Not reported^{note 9}	840^{note 10}	892^{note 10}	367^{note 10}	Not reported^{note 11}
Capex % of sales (investeringer i procent af omsætningen)	Not reported	Not reported	4.3%^{note 10}	2%^{note 10}	Not reported^{note 11}
NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender)	-5,633^{note 3}	-2,136^{note 3}	Not reported^{note 4}	-5,021^{note 3}	-7,081^{note 3}

Ownership

People

Network

Financials

Changes

Registry Facts

Registrations (Registreringer)

Registration

Dandex in Your Own Tools

Ownership

People

Financials

Who Is Behind It

Ownership

People

Current (0)

Founders (1)

Roles Over Time

Network

Headcount

Financials

Annual Reports

Financials

Changes

Registry Facts

Share Capital

Mergers and Demergers

Registry Facts

Registrations (Registreringer)

Registrations (Registreringer)

Registration

Production Units

Dandex in Your Own Tools

Who Is Behind It

Current (0)

Founders (1)

Roles Over Time

Headcount

Financials

Annual Reports

Registry Facts

Share Capital

Mergers and Demergers

Registrations (Registreringer)

Production Units